US Patent 8105612 Serum resistance factors of gram positive bacteria

Patent 8105612 was granted and assigned to Novartis on January, 2012 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

January 31, 2012

Patent Application Number

11920274

Date Filed

May 12, 2006

Patent Citations Received

Patent Primary Examiner

Patent abstract

A newly identified serum resistance factor of gram positive bacteria can be used to treat or prevent bacterial infection.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 8105612 Serum resistance factors of gram positive bacteria

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.